Compare HubSpot Inc (HUBS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HubSpot Inc vs TransMedics Group Inc — how do they compare? HubSpot Inc trades at $224.72 (market cap $11.84B), while TransMedics Group Inc trades at $73.86 (market cap $2.54B). The key difference: HubSpot Inc is far larger — about 4.7× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| HUBS | TMDX | |
|---|---|---|
Market Cap | $11.84B | $2.54B |
Sector | Technology | Technology |
52-Week High | $560.90 | $150.42 |
52-Week Low | $170.39 | $61.99 |
Enterprise Value | $10.39B | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HubSpot (HUBS) trades at $231.36, up 3.17% with strong technical momentum and bullish moving averages. The company demonstrates robust revenue growth, reaching $3.13B in 2025 with expanding profit margins. Recent earnings consistently beat expectations, and analyst sentiment remains overwhelmingly positive with 81% buy ratings. Technical indicators show the stock approaching resistance at $232 with RSI levels suggesting potential overbought conditions.
HUBS presents compelling growth prospects with accelerating AI integration and customer expansion, though elevated valuation metrics and competitive pressures warrant caution. The stock's 14% upside to consensus target of $264.06 reflects optimism about continued execution, but investors should monitor margin sustainability and market volatility risks in the software sector.
TransMedics (TMDX) trades at $73.47, down 0.69% with neutral technical signals. The stock shows strong profitability with 27% net margins and 45% ROE, though Q1 2026 earnings missed expectations. Recent strategic investment in European aviation logistics aims to expand the Organ Care System platform. Analyst consensus remains bullish with a $108.71 price target representing 48% upside potential.
Long-term growth prospects appear solid given TMDX's expanding transplant ecosystem, but near-term margin pressure from expansion investments and execution risks warrant caution. The company maintains competitive advantages in organ transplant logistics, though increased spending and competitive threats from alternatives like Strata Critical Medical present headwinds for shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
